biblio
, “Synthesis and antimycobacterial screening of a novel series of alpha-amino acids containing thiazole linker”, ARKIVOC, 2022.
, “Synthesis and antimycobacterial screening of new 4-(4-(1-benzyl-1H-1,2,3-triazol-4-yl)-1-phenyl-1H-pyrazol-3-yl)quinoline derivatives”, Journal of Heterocyclic Chemistry, vol. 57, no. 11, pp. 3918-3929, 2020.
, “Synthesis and antimycobacterial screening of new thiazolyl-oxazole derivatives”, European Journal of Medicinal Chemistry, vol. 132, pp. 333-340, 2017.
, “Synthesis and antitubercular activity of new 1,3,4-oxadiazoles bearing pyridyl and thiazolyl scaffolds”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 15, pp. 3646-3651, 2016.
, “Synthesis and antitubercular activity of new benzo[b]thiophenes”, ACS Medicinal Chemistry Letters, vol. 7, no. 8, pp. 751-756, 2016.
, “Synthesis and antitubercular activity of new thiazolidinones with pyrazinyl and thiazolyl scaffolds”, Journal of Heterocyclic Chemistry, vol. 54, no. 1, pp. 125-130, 2017.
, “Synthesis and bioactivity of novel triazole incorporated benzothiazinone derivatives as antitubercular and antioxidant agent”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 2, pp. 561-569, 2016.
, “Synthesis and biological evaluation of 1,2,4-triazole-3-thione and 1,3,4-oxadiazole-2-thione as anti-mycobacterial agents”, Chemical Biology & Drug Design, vol. 90, no. 2, pp. 200-209, 2017.
, “Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis”, European Journal of Medicinal Chemistry, vol. 178, pp. 315-328, 2019.
, “Synthesis and biological evaluation of new 2-aryl-4-((4-aryl-1H-1,2,3-triazol-1-yl)methyl)thiazole derivatives”, Research on Chemical Intermediates, vol. 44, no. 2, pp. 1247-1260, 2018.
, “Synthesis and biological evaluation of new 4-(4-(1-benzyl-1H-1,2,3-triazol-4-yl)phenyl)-2-phenylthiazole derivatives”, Journal of Heterocyclic Chemistry, 2019.
, “Synthesis and biological evaluation of new fluconazole β-lactam conjugates linked via 1,2,3-triazole”, New Journal of Chemistry, vol. 41, no. 2, pp. 470-479, 2017.
, “Synthesis and biological evaluation of novel triazole-biscoumarin conjugates as potential antitubercular and anti-oxidant agents”, Research on Chemical Intermediates, vol. 44, no. 10, pp. 1-28, 2018.
, “Synthesis and biological evaluation of some bicyclic [2-(2,4-dimethylphenylthio)phenyl] aniline and its amide derivatives as potential antitubercular agents”, Journal of Chemical Sciences, vol. 130, no. 3, p. 22, 2018.
, “Synthesis and biological evaluation of some new tricyclic pyrrolo[3,2-e]tetrazolo[1,5-c]pyrimidine derivatives as potential antitubercular agents”, Archiv Der Pharmazie, vol. 351, no. 8, p. e1800040, 2018.
, “Synthesis and cell imaging applications of fluorescent mono/di/tri-heterocycl- yl-2,6-dicyanoanilines”, Bioorganic & Medicinal Chemistry Letters, vol. 27, no. 4, pp. 979-988, 2017.
, “Synthesis and cell imaging applications of fluorescent mono/di/tri-heterocyclyl-2,6-dicyanoanilines (vol 27, pg 979, 2017)”, Bioorganic & Medicinal Chemistry Letters, vol. 32, p. 127737, 2021.
, “Synthesis and docking studies of pyrazine-thiazolidinone hybrid scaffold targeting dormant tuberculosis”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 9, pp. 2224-2228, 2016.
, “Synthesis and evaluation of thieno[2,3-d]pyrimidin-4(3H)-ones as potential antitubercular agents (vol 6, pg 2209, 2015)”, Medchemcomm, vol. 7, no. 2, p. 379, 2016.
, “Synthesis and evaluation of thieno[2,3-d]pyrimidin-4(3H)-ones as potential antitubercular agents”, MedChemComm, vol. 6, no. 12, pp. 2209-2215, 2015.
, “Synthesis and tyrosinase inhibition activity of trans-stilbene derivatives”, Bioorganic Chemistry, vol. 64, pp. 97-102, 2016.
, “Synthesis, antimycobacterial screening and molecular docking studies of 4-aryl-4′-methyl-2′-aryl-2,5′-bisthiazole derivatives”, Medicinal Chemistry Research, 2017.
, “Synthesis, biological evaluation and molecular docking of novel coumarin incorporated triazoles as antitubercular, antioxidant and antimicrobial agents”, Medicinal Chemistry Research, vol. 25, no. 4, pp. 790-804, 2016.
, “Synthesis, biological evaluation and molecular docking studies of N-acylheteroaryl hydrazone derivatives as antioxidant and anti-inflammatory agents”, Research on Chemical Intermediates, vol. 42, no. 3, pp. 2707-2729, 2016.
, “Synthesis, biological evaluation, and molecular docking studies of novel 3-aryl-5-(alkyl-thio)-1H-1,2,4-triazoles derivatives targeting Mycobacterium tuberculosis”, Chemical Biology & Drug Design, vol. 90, no. 6, pp. 1206-1214, 2017.
, “Synthesis, biological evaluation, and molecular docking study of pyridine clubbed 1,3,4-oxadiazoles as potential antituberculars”, Synthetic Communications, vol. 48, no. 5, pp. 524-540, 2018.
, “Synthesis, biological evaluation and molecular docking study of some novel indole and pyridine based 1,3,4-oxadiazole derivatives as potential antitubercular agents”, Bioorganic & Medicinal Chemistry Letters, vol. 26, no. 7, pp. 1776-1783, 2016.
, “Synthesis of new 1,3,4-oxadiazole and benzothiazolylthioether derivatives of 4-arylmethylidene-3-substituted-isoxazol-5(4H)-one as potential antimycobacterial agents”, Medicinal Chemistry Research, vol. 28, no. 11, pp. 1873-1884, 2019.
, “Synthesis of new 2-(thiazol-4-yl)thiazolidin-4-one derivatives as potential anti-mycobacterial agents”, Bioorganic Chemistry, vol. 115, p. 105192, 2021.
, “Synthesis of new thiazole and pyrazole clubbed 1,2,3-triazol derivatives as potential antimycobacterial and antibacterial agents”, Polycyclic Aromatic Compounds, vol. 42, no. 6, pp. 3216-3237, 2022.
, “Synthesis of novel triazole-incorporated isatin derivatives as antifungal, antitubercular, and antioxidant agents and molecular docking study”, Journal of Heterocyclic Chemistry, vol. 54, no. 413, 2017.
, “Targeting dormant tuberculosis bacilli: results for molecules with a novel pyrimidone scaffold”, Chemical Biology & Drug Design, vol. 85, no. 2, pp. 201-207, 2015.
, “Tetrazoloquinoline-1,2,3-triazole derivatives as antimicrobial agents: synthesis, biological evaluation and molecular docking study”, Polycyclic Aromatic Compounds, vol. 42, no. 4, pp. 1920-1941, 2022.
, “Thiazolyl-pyrazole derivatives as potential antimycobacterial agents”, Bioorganic & Medicinal Chemistry Letters, vol. 29, no. 10, pp. 1199-1202, 2019.
, “Total synthesis, structure elucidation and expanded bioactivity of icosalide A: effect of lipophilicity and ester to amide substitution on its bioactivity”, Organic & Biomolecular Chemistry, vol. 21, no. 28, pp. 5725-5731, 2023.
, “Triazole-diindolylmethane conjugates as new antitubercular agents: synthesis, bioevaluation, and molecular docking”, MedChemComm, vol. 9, no. 7, pp. 1114-1130, 2018.
, “Two antibacterial spiro compounds from the roots of Artemisia pallens wall: evidence from molecular docking”, Natural Product Research, vol. 36, no. 10, pp. 2465-2472, 2022.
, “Two chitotriose-specific lectins show anti-angiogenesis, induces caspase-9-mediated apoptosis and early arrest of pancreatic tumor cell cycle”, Plos One, vol. 11, no. 1, p. Article Number: e0146110, 2016.
, “Ultrasound assisted synthesis of 4-(Benzyloxy)-N-(3-chloro-2-(substitutedphenyl)-4-oxoazetidin-1-yl) benzamide as challenging anti-tubercular scaffold”, Molecules, vol. 23, no. 8, p. Article No: 1945, 2018.
, “Using diphenyleneiodonium to induce a viable but non-culturable phenotype in Mycobacterium tuberculosis and its metabolomics analysis”, Plos One, vol. 14, no. 8, p. e0220628, 2019.